Blood Flow Measurement Devices Market – Strategy Adopted by the players

-
The blood flow measurement devices market is projected to reach USD 533.0 Million by 2021 from USD 343.6 Million in 2016, growing at a CAGR of 9.2% in the next five years (2016 to 2021).
Blood flow measurement devices are used to measure the volume rate of blood flow, which helps physicians to maintain equilibrium between blood supply and demand of tissue oxygen of patients. The measurement of blood flow helps in identifying blockages in the blood vessels and testing artificial blood vessels during organ transplantation, among others. These devices are imperative for diagnosing various clinical vascular conditions such as arterial occlusion, peripheral vascular diseases including diabetes, micro- and macro-vascular complications. The devices also find applications in skin testing, cerebral blood flow measurement, and burn assessment.
The major market players in the blood flow measurement devices market include Medistim ASA (Norway), Transonic Systems, Inc. (U.S.), Cook Medical, Inc. (U.S.), Moor Instruments Ltd. (U.K.), ADInstruments (Australia), SONOTEC Ultraschallsensorik Halle GmbH (Germany), Deltex Medical Group plc (U.K.), Atys Medical (France), Compumedics Ltd. (Australia), Perimed AB (Sweden), and BIOPAC Systems, Inc. (U.S.).

Product launches, product enhancements, and product extensions accounted for 42% of the total number of strategic developments undertaken by market players during 2013 to 2017 Players adopted this strategy to develop, commercialize, and expand their product & services portfolio, so as to strengthen their customer base and provide better access to their clients. The key players that adopted this strategy are Medistim ASA (Norway), SONOTEC Ultraschallsensorik Halle GmbH (Germany), Cook Medical, Inc. (U.S.), and ADInstruments (Australia).

Comments

Post a Comment

Popular posts from this blog

Future of Remote Patient Monitoring Industry: Impact of Remote Patient Monitoring on Healthcare

-
Remote patient monitoring is a type of telemedicine technology that enables healthcare providers to monitor their patients’ health remotely. This technology utilizes remote devices that are placed in the patient’s home or worn by the patient to collect medical data such as vital signs and other medical information.  This medical data is then transmitted to the doctor or healthcare provider to help them make better decisions regarding the patient’s care. RPM can be used to monitor a variety of conditions including chronic diseases, mental health issues, and post-operative care. It can also be used to support elderly individuals and those with disabilities. RPM has the potential to improve patient outcomes and reduce healthcare costs by enabling healthcare providers to monitor their patients’ health more effectively. Benefits of Remote Patient Monitoring 1. Increased Patient Engagement: Remote patient monitoring systems provide patients with a convenient way to stay engaged in thei...
Read more

Strategies Adopted by the Major Players in this Digital PCR Market

-
 According to research report the  Digital PCR Market  is expected to grow from USD 3.47 billion in 2017 to USD 5.31 billion by 2022, at a CAGR of 8.9% during the forecast period. Product Launches: Key Strategy Adopted by the Major Players in this Market New product launches and approvals are the key growth strategies adopted by major players to strengthen their position in the global Digital PCR Market. Moreover, strategies such as partnerships, collaborations, and agreements; as well as mergers and acquisitions were also adopted by several market players to strengthen their market position, expand their R&D capabilities, and geographic presence in the global Digital PCR Market. The key players in the Digital PCR Market include Thermo Fisher Scientific, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (US), QIAGEN N.V. (Netherlands), Takara Bio, Inc. (Japan), Agilent Technologies, Inc. (US), bioMérieux S.A. (France), Fluid...
Read more

Sinus Dilation Devices Market Size And Share Report, 2027

-
The sinus dilation devices market is on track for significant growth in the coming years, projected to reach USD 3.8 billion by 2027, up from USD 2.8 billion in 2022. This represents a compound annual growth rate (CAGR) of 6.6% during the forecast period. The market's expansion is largely driven by the increasing availability of reimbursements and rising cases of chronic sinusitis. However, the market faces challenges due to the availability of non-surgical treatments for chronic sinusitis and a shortage of skilled ENT surgeons. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=64349810 Key Market Drivers Increasing Availability of Reimbursements: The growing availability of reimbursements for sinus dilation procedures is making them more accessible to patients, thereby driving demand for sinus dilation devices. Rising Incidence of Chronic Sinusitis: The prevalence of chronic sinusitis is on the rise globally, leading to an increase in d...
Read more